5 06, 2023 Phase 1 randomized, observer-blinded, placebo-controlled study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B Neal Evan Caminsky2023-06-05T15:18:38-04:00June 5, 2023|Funded Research Results, Pillar 4|
20 04, 2023 Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade Neal Evan Caminsky2023-10-13T10:18:47-04:00April 20, 2023|Funded Research Results, Pillar 10|
20 04, 2023 Cross-continental collaboration identifies new COVID-blocking natural product Neal Evan Caminsky2023-04-20T21:07:29-04:00April 20, 2023|News releases and statements|
13 04, 2023 High steady state of COVID-19 case levels are a concern, according to CoVaRR-Net experts Neal Evan Caminsky2023-04-09T08:04:25-04:00April 13, 2023|News releases and statements|
4 04, 2023 Zooanthroponotic transmission of SARS-CoV-2 and host-specific viral mutations revealed by genome-wide phylogenetic analysis Neal Evan Caminsky2023-04-04T16:22:13-04:00April 4, 2023|Funded Research Results, Pillar 6|
17 03, 2023 SARS-CoV-2 Nsp2 contributes to inflammation by activating NF-kB Neal Evan Caminsky2023-03-17T09:37:00-04:00March 17, 2023|Funded Research Results, Pillar 3|
17 03, 2023 Natural evolution of SARS-CoV-2 variants in K18-ACE2 mice gives rise to more virulent virus and variant alleles associated with treatment resistance Neal Evan Caminsky2023-03-17T09:32:07-04:00March 17, 2023|Funded Research Results, Pillar 3|
7 03, 2023 CoVaRR-Net CAMEO presentation to NACI Neal Evan Caminsky2023-03-17T12:44:29-04:00March 7, 2023|News releases and statements|
22 02, 2023 Comparison of COVID-19 vaccination rollout approaches across Canada: case studies of four diverse provinces Neal Evan Caminsky2023-02-24T14:36:10-05:00February 22, 2023|Funded Research Results, Pillar 8|
7 02, 2023 CoVaRR-Net research advancing wastewater and surface testing in planes as early warning for new SARS-CoV-2 variants and other disease threats Neal Evan Caminsky2023-02-06T11:38:41-05:00February 7, 2023|Hot Topic|
